Published in Biochim Biophys Acta on February 26, 1979
Detection of hepatitis-B surface antigen in blood and blood products dried on filter paper. Lancet (1978) 2.48
Studies of an unusual hemoglobin in patients with diabetes mellitus. Biochem Biophys Res Commun (1969) 1.78
An abnormal hemoglobin in red cells of diabetics. Clin Chim Acta (1968) 1.76
The prevalence of hepatitis B surface antigen and its antibody in blood donors and high risk groups in Iran. Vox Sang (1979) 1.31
Two haemoglobins Q, alpha-74 (EF3) and alpha-75 (EF4) aspartic acid to histidine. Br J Haematol (1970) 1.28
Discrimination among the transcripts of the allelic human beta-globin genes beta A, beta S and beta C using oligodeoxynucleotide hybridization probes. Gene (1986) 1.20
Single-tube polymerase chain reaction for rapid diagnosis of the inversion hotspot of mutation in hemophilia A. Blood (1998) 1.12
Haemoglobin D Iran: 2 22 glutamic acid leads to glutamine (B4). Br J Haematol (1973) 1.07
Genes and people in the Caspian Littoral: a population genetic study in Northern Iran. Am J Phys Anthropol (1977) 1.06
Detection of virtually all mutations-SSCP (DOVAM-S): a rapid method for mutation scanning with virtually 100% sensitivity. Biotechniques (1999) 1.05
A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats. Br J Ophthalmol (2008) 0.94
Isolation of fungi from housefly (Musca domestica L.) at Slaughter House and Hospital in Sanandaj, Iran. J Prev Med Hyg (2012) 0.91
Double heterozygosity for two unstable haemoglobins: Hb Sydney (beta67[E11] Val leads to Ala) and Hb Coventry (beta141[H19] Leu deleted). Br J Haematol (1978) 0.89
LR16, a compound with potent effects on the oxygen affinity of hemoglobin, on blood cholesterol, and on low density lipoprotein. Proc Natl Acad Sci U S A (1988) 0.89
Abnormal haemoglobins in Iran. Observation of a new variant--haemoglobin J Iran (alpha-2-beta-2 77 His--Asp). Br Med J (1967) 0.88
LR-90 prevents dyslipidaemia and diabetic nephropathy in the Zucker diabetic fatty rat. Diabetologia (2008) 0.88
Hemoglobin Setif (alpha94 (G1) Asp replaced by Tyr) in Iram. A report of 9 cases. Hemoglobin (1977) 0.87
LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats. Diabetologia (2003) 0.87
Hemoglobin Lepore Boston in two Iranian families. Blood (1974) 0.85
Carcinogenicity and haemoglobin synthesis induction by cytidine analogues. Br J Cancer (1988) 0.85
Haplotype analysis of the human beta-globin gene complex using multiple locus specific oligonucleotide probes. Anal Biochem (1988) 0.85
Scanning by DOVAM-S detects all unique sequence changes in blinded analyses: evidence that the scanning conditions are generic. Biotechniques (2000) 0.84
Routine laser assisted hatching results in significantly increased clincal pregnancies. J Assist Reprod Genet (2003) 0.84
Heterogeneity of von Willebrand's disease: study of 40 Iranian cases. Br J Haematol (1977) 0.83
Fetal hemoglobin gene activation in a phase II study of 5,6-dihydro-5-azacytidine for bronchogenic carcinoma. Cancer Res (1987) 0.82
Hepatitis C virus antibody positive blood donors. Gut (1993) 0.81
Molecular analyses of beta-thalassemia in Iran. Hemoglobin (1995) 0.80
How to deal with medical and social aspects of bleeding disorders--preparing women and the family in developing countries. Haemophilia (2011) 0.80
Mild sickle cell anemia associated with alpha globin mutant alpha Montgomery. Am J Med (1989) 0.80
Hemoglobin H disease in two Iranian families. Clin Chim Acta (1968) 0.80
Reverse phase high-performance liquid chromatography and secondary ion mass spectrometry. A strategy for identification of ten human hemoglobin variants. Hemoglobin (1986) 0.80
A novel alanine or threonine 789 to proline mutation causing type 2N von Willebrand's disease when inherited homozygously or heterozygously with arginine 854 to glutamine mutation. Haemophilia (2010) 0.80
Subacute sclerosing panencephalitis: clinical and immunologic study of 23 patients. Neurology (1981) 0.79
A case report of post-transfusion hepatitis A. J Med Virol (1982) 0.79
Effects of a new advanced glycation inhibitor, LR-90, on mitigating arterial stiffening and improving arterial elasticity and compliance in a diabetic rat model: aortic impedance analysis. Br J Pharmacol (2014) 0.79
Professional and voluntary blood: a preliminary study in Iran. Vox Sang (1978) 0.79
XI. The hereditary blood factors of the Kurds of Iran. Philos Trans R Soc Lond B Biol Sci (1973) 0.79
A case of homozygous haemoglobin Lepore Boston in Iran. Acta Haematol (1975) 0.79
Direct analysis of single nucleotide variation in human DNA and RNA using in situ dot hybridization. DNA (1989) 0.78
Histocompatibility antigens (HLA) in rheumatic diseases in Iran. J Rheumatol Suppl (1977) 0.78
HLA AW19, B12 in immunoproliferative small intestinal disease. Gut (1979) 0.78
Seven novel point mutations in the F11 gene in Iranian FXI-deficient patients. Haemophilia (2007) 0.78
Identification of 123 previously unreported mutations in the F8 gene of Iranian patients with haemophilia A. Haemophilia (2011) 0.78
Identification of a homozygous Cys410Ser mutation in the von Willebrand factor D2 domain causing type 2A(IIC) von Willebrand disease phenotype in an Iranian patient. Haemophilia (2013) 0.77
Haemoglobin Daneshgah-Tehran alpha2 72 (EPI) histidine--arginine betaA2. Nat New Biol (1973) 0.77
Identification of intron 1 and 22 inversion mutations in the factor VIII gene of 124 Iranian families with severe haemophilia A. Haemophilia (2004) 0.77
High frequency of Ina antigen among Iranians and Arabs. Hum Hered (1980) 0.77
Inhibition of thymidine uptake by staphylococci, a new method for the investigation of phagocytosis. J Immunol Methods (1976) 0.77
PACAP mediates the neural proliferative pathway of Mastomys enterochromaffin-like cell transformation. Regul Pept (2001) 0.77
Glycosylated hemoglobins. Tex Rep Biol Med (1982) 0.76
A silent hemoglobin variant detected by HPLC: hemoglobin City of Hope beta 69 (E13) Gly----Ser. Hemoglobin (1984) 0.76
Hemoglobin D Punjab in a Bulgarian Jewish family. Isr J Med Sci (1970) 0.76
Supply and need of factor VIII concentrates. Haematologia (Budap) (1983) 0.76
A double heterozygous hemoglobin. Hemoglobin OIndonesia and hemoglobin DPunjab in an individual. Am J Clin Pathol (1975) 0.76
The concentration of plasma fibronectin in burns patients treated with fresh frozen plasma or plasma protein fraction. Resuscitation (1984) 0.76
Histocompatibility antigens (HLA) in multiple sclerosis in Iran. J Neurol Neurosurg Psychiatry (1978) 0.75
In vitro suppression of lymphocyte blastogenic response to mitogen and antigen by Leishmania tropica. Clin Exp Immunol (1978) 0.75
Worldwide overview of plasma procurement and fractionation. Scand J Haematol Suppl (1984) 0.75
Immunoproliferative small intestinal disease and primary small intestinal lymphoma. Relation to alpha chain protein. Cancer (1985) 0.75
Transfusion-associated graft-versus-host disease: current concepts and future trends. Transfus Sci (1995) 0.75
Letter: HB Ag Y-subtypes in Iran. N Engl J Med (1974) 0.75
Hemoglobinopathies in the Los Angeles area. Hemoglobin (1983) 0.75
Immunochemical studies in a patient with Waldenstrom's macroglobulinemia. Acta Med Iran (1978) 0.75
A second case of hemoglobin McKees Rocks (beta 145 Tyr leads to Term). A variant with premature termination of the beta-chain. Hemoglobin (1983) 0.75
Splice junction [IVS-II-1 (G-->C)] thalassemia; a new mutation detected in an Iranian patient. Hemoglobin (1993) 0.75
Indirect allosteric effects of a neutral mutation. Structure of deoxyhaemoglobin north Chicago (ProC2(36)beta----Ser). J Mol Biol (1988) 0.75
A study of cell-mediated immunity and histocompatibility antigens in leprosy patients in Iran. Int J Lepr Other Mycobact Dis (1978) 0.75
Further evidence for a post-translational phenomenon in the interaction of alpha-thalassemia with sickle cell trait. Hemoglobin (1988) 0.75
Heterogeneous ontogeny of erythropoiesis after bone marrow ablation and allogeneic bone marrow grafting. Blood (1983) 0.75
Two new haemoglobins: haemoglobin Perspolis (alpha 64 (E13) Asp leads to Tyr) and haemoglobin J-Kurosh (alpha 19 (AB) Ala leads to Asp). Biochim Biophys Acta (1976) 0.75
Functional studies, anion-binding and effects of bezafibrate on three high affinity hemoglobin variants: Hb Olympia, Hb Great Lakes and Hb North Chicago. Hemoglobin (1986) 0.75
Hemoglobin Osu-Christiansborg (beta52 (D3) Aspyield Asn) in an Iranian family. Hemoglobin (1978) 0.75
[Study of the action of immunodepressive agents using the leukocyte migration test]. Acta Med Iran (1978) 0.75
Hemoglobin Great Lakes (beta 68 [E12] leucine replaced by histidine): a new high-affinity hemoglobin. Blood (1981) 0.75
Clinical outcome of interferon and ribavirin combination treatment in hepatitis C virus infected patients with congenital bleeding disorders in Iran. Haemophilia (2009) 0.75
Financial aspects of hemophilia care. Scand J Haematol Suppl (1984) 0.75
Glycosylated minor C, D, and E hemoglobins. Biochem Med (1981) 0.75
Haemoglobin Arya: alpha 2-47 (CD5), aspartic acid yields asparagine. Biochim Biophys Acta (1975) 0.75
A novel initiation codon mutation (ATG-->ATT) in a beta-thalassemia patient. Hemoglobin (1993) 0.75
Iron overload in three generations of a family with hemoglobin Olympia. Gastroenterology (1984) 0.75
Haemoglobin hamadan: alpha-2A beta-2 56 (D7) glycine yields arginine. Biochim Biophys Acta (1975) 0.75
Hemoglobin Pasadena: identification of the gene mutant by DNA analysis using synthetic DNA probes. Am J Hematol (1988) 0.75
Hemoglobin Hammersmith as the cause of severe hemolytic anemia in a Chinese girl. Am J Pediatr Hematol Oncol (1986) 0.75
Cell-mediated immunity in professional and voluntary blood donors. Vox Sang (1978) 0.75
Hb Watts [alpha 74(EF3) or alpha 75(EF4)Asp-->0]: a shortened alpha chain variant due to the deletion of three nucleotides in exon 2 of the alpha 2-globin gene. Hemoglobin (1997) 0.75
A novel intrachromosomal rearrangement in the beta-globin gene found in an African-American family. Hemoglobin (1995) 0.75
Preliminary results of transfer factor therapy of persistant cutaneous leishmania infection. Clin Immunol Immunopathol (1979) 0.75
Haemoglobin L Persian Gulf: alpha-57 (E6) glycine leads to arginine. Acta Haematol (1969) 0.75
Haemoglobin M Boston in an Iranian family. Acta Med Iran (1977) 0.75
Association of Hb Hope [beta 136(H14)Gly----Asp] and alpha-thalassemia-2 (3.7 Kb deletion) causing severe microcytic anemia. Hemoglobin (1992) 0.75
Microcytosis in Hodgkin disease associated with unbalanced globin chain synthesis. Am J Hematol (1986) 0.75
Classification of Iranian patients with Glanzmann's Thrombasthenia using a flow cytometric method. Platelets (2011) 0.75
Hemoglobin North Chicago (beta 36 [C2] proline----serine): a new high affinity hemoglobin. Hemoglobin (1985) 0.75
Favism in the Caspian littoral area of Iran. Trop Geogr Med (1971) 0.75
Haemoglobin Coventry (beta 141 deleted) in Iran. FEBS Lett (1978) 0.75
Hemoglobin G Saskatoon in association with PNH in an Iranian soldier. Hemoglobin (1981) 0.75
Mitogen-induced suppressor T cell activity in the in vitro cellular immune response. J Immunol Methods (1979) 0.75